{"title":"Acceptability of clinics for sexually transmitted diseases among users of the \"gay scene\" in the West Midlands.","authors":"J D Ross, M Shahmanesh","doi":"10.1136/sti.73.6.580-a","DOIUrl":null,"url":null,"abstract":"I welcome the imminent arrival of type specific antibody tests for herpes' which will help in the management of certain clinical situations. However, I am not convinced that these tests should be used to screen large sections of the population until a more thorough evaluation of the costs, benefits, and harm that such a programme would generate has been undertaken. There are other pressing needs in sexual health and GU medicine cannot afford to back a poor horse. Given the high prevalence of HSV 2 in STD clinic patients further attention to promoting safer sex in these patients and in the wider population may be more beneficial than costly technological interventions. DAVID M COKER Department of Genitourinary Medicine, Furness General Hospital, Dalton Lane, Barrow in Furness, Cumbria 1 Ashley RL, Corey L. HSV type specific antibody tests: patients are ready, are clinicians? Genitourin Med 1997;73:235-6.","PeriodicalId":12621,"journal":{"name":"Genitourinary Medicine","volume":"73 6","pages":"580"},"PeriodicalIF":0.0000,"publicationDate":"1997-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/sti.73.6.580-a","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genitourinary Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/sti.73.6.580-a","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
I welcome the imminent arrival of type specific antibody tests for herpes' which will help in the management of certain clinical situations. However, I am not convinced that these tests should be used to screen large sections of the population until a more thorough evaluation of the costs, benefits, and harm that such a programme would generate has been undertaken. There are other pressing needs in sexual health and GU medicine cannot afford to back a poor horse. Given the high prevalence of HSV 2 in STD clinic patients further attention to promoting safer sex in these patients and in the wider population may be more beneficial than costly technological interventions. DAVID M COKER Department of Genitourinary Medicine, Furness General Hospital, Dalton Lane, Barrow in Furness, Cumbria 1 Ashley RL, Corey L. HSV type specific antibody tests: patients are ready, are clinicians? Genitourin Med 1997;73:235-6.